Conference Agenda
Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).
Please note that all times are shown in the time zone of the conference. The current conference time is: 24th Aug 2026, 01:52:00am WEST
External resources will be made available 30 min before a session starts. You may have to reload the page to access the resources.
|
Daily Overview |
| Session | |
|
Economic Valuation and Health Location: B128 Session Chair: Iva Zvěřinová, Charles University | |
    | |
Willingness to Pay to Reduce Risk of Hospitalization and Long-term Health Impacts of Infectious Illnesses: A U.S. Discrete Choice Experiment 1: George Washington University, United States of America; 2: Resources for the Future, United States of America; 3: University of Western Australia, Australia; 4: University of Manchester, United Kingdom There is growing recognition of the need for estimates of willingness to pay (WTP) to reduce risk of non-fatal health outcomes to inform public decisions. A major reason for this gap in the health valuation literature is simply the great diversity of non-fatal illnesses, what a high-level US evaluation called the “high dimensionality” of morbidity. This paper explores one approach to addressing the “high dimensionality” challenge in health valuation, using one stated preference survey to elicit WTP for multiple types of illness. We present results from a U.S. population survey of willingness to pay to reduce risk of eleven serious short-term complications and long-term chronic outcomes of infectious illnesses. The short-term complications include hospitalization for diarrhea/dehydration, hospitalization with bloody diarrhea, sepsis, appendectomy, and short-term kidney impairment (HUS). The longer-term or chronic health outcomes include irritable bowel syndrome (IBS), Guillan-Barré syndrome (GBS), reactive arthritis, permanent kidney failure (End Stage Renal Disease or ESRD), permanent vision impairment, and chronic outcomes from meningitis. We estimate a double bounded probit model that allows us to generatd by employment status and race. We find that respondents are sensitive to the cost of reducing risk, and the level of risk reduction. We also report estie estimates of WTP to reduce the risk of experiencing these health outcomes, moderatemates of the value of a statistical case. These range from $0.86m to $1.46 million depending on the severity of the disease. | |